ETFChannel.com
ETF Introduction: IBB — iShares Biotechnology ETF
Market News Video - Monday, April 6, 5:28 PM

Description to the Nasdaq Biotechnology Index Fund, traded under ticker symbol IBB: This ETF is a fund, created in February 2001, that corresponds to the price and yield performance, before fees and expenses, of companies primarily in the biotech sector, as represented by the NASDAQ Biotechnology Index. The underlying index includes securities of Nasdaq listed companies classified according to the Industry Classification Benchmark as either Biotech or Pharma which also meet other eligibility criteria.

Fund Name:
iShares Biotechnology ETF
Issuer:
iShares
Total Net Assets:
$7,195,059,121
Inception:
NA
Related Index:
NASDAQ Biotechnology Index (NBI)
ETF Category: 
Health
Expense Ratio: 
0.45% 
Net Asset Value: 
$113.42  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
IBB.NV  
Number of Holdings: 
268  
Annualized Yield: 
0.30%  
Annualized Distribution: 
0.336  
IBB Dividend History » 
Stock Weight Amount
Amgen 9.01% $659,242,532
Gilead Sciences 6.10% $446,525,313
Vertex Pharmaceuticals 4.65% $340,466,693
Regeneron Pharmaceuticals 4.16% $304,369,552
Illumina 3.40% $248,932,886
List of all 272 stocks held by IBB »
Quotes delayed 20 minutes

Email EnvelopeFree IBB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.07 out of 4)
0th percentile
(ranked lower than approx. 100% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
ETF Assets
IVV   $273,025,121,591
AGG   $78,777,356,207
IEFA   $75,601,620,894
IJR   $58,909,051,285
IEMG   $58,293,202,269
List of all 316 others »
Shares Short 11,030,000
Chg. from Last Month -1,890,000
Shares Outstanding 64,500,000
% of Shares Short 17.10%
Days to Cover 6.5
Based on third party short interest data.

IBB | iShares Biotechnology ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.